Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Stage IV Ampulla of Vater Cancer

University of NebraskaSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Stage IV Ampulla of Vater Cancer cohort.

Asset / SponsorPhaseRating
Docetaxel
Minia University
Phase 3BB
PANTOPRAZOLE
Washington University School of Medicine
Phase 2CCC
Dostarlimab
UNICANCER
Phase 2CCC
Irinotecan
University of Chicago
Phase 1CC
ADH-1 TRIFLUROACETATE
University of Nebraska
Phase 1CC
FLUOROURACILUM
Alliance for Clinical Trials in Oncology
Phase 1CC
Eloxatin
Alliance for Clinical Trials in Oncology
N/AD

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →